Nina Mars

11.9k total citations · 1 hit paper
38 papers, 973 citations indexed

About

Nina Mars is a scholar working on Genetics, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Nina Mars has authored 38 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 7 papers in Surgery and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Nina Mars's work include Genetic Associations and Epidemiology (14 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Nina Mars is often cited by papers focused on Genetic Associations and Epidemiology (14 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Autoimmune and Inflammatory Disorders Research (4 papers). Nina Mars collaborates with scholars based in Finland, United States and United Kingdom. Nina Mars's co-authors include Samuli Ripatti, Aarno Palotie, Joni V. Lindbohm, Veikko Salomaa, Aki S. Havulinna, Pietari Ripatti, Tuomo Kiiskinen, Matti Pirinen, Elisabeth Widén and Jukka Koskela and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Nina Mars

38 papers receiving 963 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers

2020 245 citations Nina Mars, Jukka Koskela et al. Nature Medicine profile →

Peers

Countries citing papers authored by Nina Mars

Since Specialization

Citations

This map shows the geographic impact of Nina Mars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nina Mars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nina Mars more than expected).

Fields of papers citing papers by Nina Mars

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nina Mars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nina Mars. The network helps show where Nina Mars may publish in the future.

Co-authorship network of co-authors of Nina Mars

This figure shows the co-authorship network connecting the top 25 collaborators of Nina Mars. A scholar is included among the top collaborators of Nina Mars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nina Mars. Nina Mars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An immunogenetic basis for lung cancer risk 2024 ·Science ·Chirag Krishna, (unknown), Miriam Saffern, E. A. Wilson, Seong‐Keun Yoo, Nina Mars, Vladimir Roudko, (unknown), Samuel E. Jones, Natalie Vaninov, Myvizhi Esai Selvan, Zeynep H. Gümüş, (unknown), Tobias L. Lenz, Miriam Mérad, Paolo Boffetta, Francisco Martínez-Jiménez, Hanna M. Ollila, Robert Samstein, Diego Chowell	15
2	Genome-wide polygenic risk scores for colorectal cancer have implications for risk-based screening 2024 ·British Journal of Cancer ·(unknown), Bradley Jermy, Toni T. Seppälä, Martti Färkkilâ, (unknown), Elisabeth Widén, Samuli Ripatti, Nina Mars	8
3	Genetics of sleep medication purchases suggests causality from sleep problems to psychiatric traits 2023 ·SLEEP ·Martin Broberg, (unknown), Tuomo Kiiskinen, Tiina Paunio, Samuel E. Jones, Nina Mars, Jacqueline M. Lane, (unknown), Richa Saxena, Hanna M. Ollila	8
4	Estimating Dementia Risk Using Multifactorial Prediction Models 2023 ·JAMA Network Open ·Mika Kivimäki, Gill Livingston, Archana Singh‐Manoux, Nina Mars, Joni V. Lindbohm, Jaana Pentti, Solja T. Nyberg, Matti Pirinen, Emma L. Anderson, Aroon D. Hingorani, Pyry N. Sipilä	22
5	Integration of Biomarker Polygenic Risk Score Improves Prediction of Coronary Heart Disease 2023 ·JACC Basic to Translational Science ·Jake Lin, Nina Mars, Yu Fu, Pietari Ripatti, Tuomo Kiiskinen, Taru Tukiainen, Samuli Ripatti, Matti Pirinen	7
6	Genetic risk factors have a substantial impact on healthy life years 2022 ·Nature Medicine ·Sakari Jukarainen, Tuomo Kiiskinen, (unknown), Aki S. Havulinna, Juha Karjalainen, Mattia Cordioli, Joel Rämö, Nina Mars, (unknown), Kaitlin E. Samocha, Hanna M. Ollila, Matti Pirinen, Andrea Ganna	29
7	Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot study 2022 ·European Heart Journal Open ·Margus Viigimaa, Mikk Jürisson, Heti Pisarev, Ruth Kalda, Helene Alavere, Alar Irs, Aet Saar, Krista Fischer, Kristi Läll, (unknown), Nina Mars, Elisabeth Widén, Samuli Ripatti, Andres Metspalu	7
8	How Communicating Polygenic and Clinical Risk for Atherosclerotic Cardiovascular Disease Impacts Health Behavior: an Observational Follow-up Study 2022 ·Circulation Genomic and Precision Medicine ·Elisabeth Widén, Nella Junna, Sanni Ruotsalainen, Ida Surakka, Nina Mars, Pietari Ripatti, Juulia Partanen, J. Aro, Pekka Mustonen, (unknown), Aarno Palotie, Veikko Salomaa, Jaakko Kaprio, Jukka Partanen, Kristina Hotakainen, Pasi Pöllänen, Samuli Ripatti	69
9	Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents 2022 ·Scandinavian Journal of Rheumatology ·Anne M Kerola, Silvia Rollefstad, (unknown), Grunde Wibetoe, (unknown), Nina Mars, Markku Kauppi, Tore K Kvien, Espen A. Haavardsholm, (unknown)	19
10	Immune system-wide Mendelian randomization and triangulation analyses support autoimmunity as a modifiable component in dementia-causing diseases 2022 ·Nature Aging ·Joni V. Lindbohm, Nina Mars, Pyry N. Sipilä, Archana Singh‐Manoux, Heiko Runz, (unknown), Gill Livingston, Sudha Seshadri, Ramnik J. Xavier, Aroon D. Hingorani, Samuli Ripatti, Mika Kivimäki	23
11	Systematic comparison of family history and polygenic risk across 24 common diseases 2022 ·The American Journal of Human Genetics ·Nina Mars, Joni V. Lindbohm, Pietro Della Briotta Parolo, Elisabeth Widén, Jaakko Kaprio, Aarno Palotie, Samuli Ripatti	77
12	Predictive Accuracy of a Clinical and Genetic Risk Model for Atrial Fibrillation 2021 ·Circulation Genomic and Precision Medicine ·Shaan Khurshid, Nina Mars, Christopher M. Haggerty, (unknown), Lu‐Chen Weng, Dustin N. Hartzel, Kathryn L. Lunetta, Jeffrey M. Ashburner, Christopher D. Anderson, Emelia J. Benjamin, Veikko Salomaa, Patrick T. Ellinor, (unknown), (unknown), Ludovic Trinquart, Steven A. Lubitz	22
13	Polygenic Risk Scores Predict Hypertension Onset and Cardiovascular Risk 2021 ·Hypertension ·Felix Vaura, Anni Kauko, Karri Suvila, Aki S. Havulinna, Nina Mars, Veikko Salomaa, (unknown), Susan Cheng, Teemu Niiranen	72
14	Clinical Conditions and Their Impact on Utility of Genetic Scores for Prediction of Acute Coronary Syndrome 2021 ·Circulation Genomic and Precision Medicine ·Jiwoo Lee, Tuomo Kiiskinen, Nina Mars, Sakari Jukarainen, Erik Ingelsson, Benjamin M. Neale, Samuli Ripatti, Pradeep Natarajan, Andrea Ganna	4
15	Polygenic burden has broader impact on health, cognition, and socioeconomic outcomes than most rare and high-risk copy number variants 2021 ·Molecular Psychiatry ·Elmo Saarentaus, Aki S. Havulinna, Nina Mars, Ari Ahola‐Olli, Tuomo Kiiskinen, Juulia Partanen, Sanni Ruotsalainen, Mitja Kurki, (unknown), (unknown), Markus Perola, Veikko Salomaa, Juha Veijola, Minna Männikkö, Ira M. Hall, Olli Pietiläinen, Jaakko Kaprio, Samuli Ripatti, Mark J. Daly, Aarno Palotie	7
16	OP0007 MUC5B PROMOTER VARIANT AND LONG-TERM INCIDENCE OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS: A POPULATION BIOBANK STUDY OF 250,000 INDIVIDUALS 2021 ·Annals of the Rheumatic Diseases ·(unknown), Tarja Laitinen, Jukka Koskela, Aarno Palotie, Nina Mars	1
17	Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers 2021 ·Annals of the Rheumatic Diseases ·Antti Palomäki, Aarno Palotie, Jukka Koskela, Kari K. Eklund, Matti Pirinen, Samuli Ripatti, Tarja Laitinen, Nina Mars	29
18	Polygenic Hyperlipidemias and Coronary Artery Disease Risk 2020 ·UTUPub (University of Turku) ·(unknown), Pietari Ripatti, Joel Rämö, Nina Mars, Yu Fu, Jake Lin, Sanni Söderlund, Christian Benner, Ida Surakka, Tuomo Kiiskinen, Aki S. Havulinna, Priit Palta, Nelson B. Freimer, Elisabeth Widén, Veikko Salomaa, Taru Tukiainen, Matti Pirinen, Aarno Palotie, Marja‐Riitta Taskinen, Samuli Ripatti	55
19	Genomic prediction of alcohol-related morbidity and mortality 2020 ·Translational Psychiatry ·Tuomo Kiiskinen, Nina Mars, Teemu Palviainen, Jukka Koskela, Joel Rämö, Pietari Ripatti, Sanni Ruotsalainen, Aarno Palotie, Pamela A. F. Madden, Richard J. Rose, Jaakko Kaprio, Veikko Salomaa, Pia Mäkelä, Aki S. Havulinna, Samuli Ripatti	11
20	Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers breakdown → 2020 ·Nature Medicine ·(unknown), Nina Mars, Jukka Koskela, Pietari Ripatti, Tuomo Kiiskinen, Aki S. Havulinna, Joni V. Lindbohm, Ari Ahola‐Olli, Mitja Kurki, Juha Karjalainen, Priit Palta, Benjamin M. Neale, Mark J. Daly, Veikko Salomaa, Aarno Palotie, Elisabeth Widén, Samuli Ripatti	245

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact